Is Autologous Hematopoietic Stem Cell Transplant Better Than High-Efficacy Disease-Modifying Therapies for Relapsing Multiple Sclerosis?

Jeffrey A. Cohen, Anne H. Cross

Research output: Contribution to journalEditorial

Original languageEnglish
Pages (from-to)669-672
Number of pages4
JournalJAMA Neurology
Volume80
Issue number7
DOIs
StatePublished - Jul 10 2023

Cite this